Genomic determinants of response to alpelisib plus fulvestrant in the SOLAR-1 trial. - Juric D; Rugo HS; Reising A; Vervier K; Ma C; Ciruelos EM; Loibl S; Singer CF; Sohn J; Campone M; Conte P; Iwata H; et al. (Annals of oncology : official journal of the European Society for Medical Oncology, 2026)